Here we present the crystal structures of the C-terminal domain from the NSP protein BCAR3 and the complex of NSP3 with p130Cas. BCAR3 adopts the Cdc25-homology fold of Ras GTPase exchange factors, but it has a 'closed' conformation incapable of enzymatic activity. The structure of the NSP3-p130Cas complex reveals that this closed conformation is instrumental for interaction of NSP proteins with a focal adhesion-targeting domain present in Cas proteins. This enzyme-to-adaptor conversion enables high-affinity, yet promiscuous, interactions between NSP and Cas proteins and represents an unprecedented mechanistic paradigm linking cellular signaling networks.
a r t i c l e s
The integration of signals triggered by diverse stimuli is essential for cell communication in higher organisms and is achieved primarily through the assembly of multiprotein signaling nodes. The Cas and NSP families form one such class of signaling nodes and correspondingly harbor multiple protein-protein interaction domains and motifs that mediate association with many cell signaling factors. This allows them to function as mediators that integrate signals emanating from cell adhesion and environmental stimuli to promote cell migration, adhesion and invasion. Dysregulation of signaling through Cas and NSP proteins is relevant to a spectrum of disease processes, particularly tumor progression and cancer metastasis.
The complexity of NSP-Cas functions is exemplified by two prominent family members, p130Cas and the NSP protein BCAR3, which also confer antiestrogen resistance in breast cancer 1, 2 . Firmly embedded in the Src-Crk signaling axis, p130Cas interacts with more than a dozen signaling factors in addition to Src family kinases and Crk, including FAK, PYK2, FRNK, RapGEF1, Aurora kinase A, PI3K, NMP4, NCK1 and SHIP2 (reviewed in ref. 3) . BCAR3 is associated with enhanced PI3K activity downstream of growth factor receptors and with subsequent activation of Rac, Cdc42, AKT and PAK1 (ref. 4 ). p130Cas and BCAR3 also bind directly to each other 5 , thereby linking their respective signaling networks to form a platform that mediates migratory signaling. In addition to BCAR3, p130Cas can also interact with NSP family members NSP3 and NSP1 (refs. 6,7) . BCAR3 also interacts with HEF1 (Cas-L) in addition to p130Cas 8 . Further combinations are created by association of NSP family members NSP3 and NSP1 with Cas proteins Cas-L and Efs, increasing the diversity of NSP-Cas signaling networks [9] [10] [11] . NSP and Cas family proteins can therefore propagate class-specific but promiscuous combinatorial networks, which are essential to their diverse functions in specialized cellular processes. The effect of aberrant NSP-Cas signaling is manifested in a range of disease processes. p130Cas and BCAR3 exert a concerted effect in cancer 12, 13 , whereas the NSP3 (SHEP1)-Cas-L signaling node is crucial for B-cell migration and maturation 9, 11 . Additionally, the NSP3-p130Cas module is essential in neuronal cells for proper olfactory development, and its absence causes a phenotype reminiscent of the human developmental disorder Kallmann syndrome 14 . These examples underline the importance of distinct NSP-Cas modules in cellular processes that require integration of adhesion and chemotactic stimuli.
Although the respective C-terminal domains of Cas and NSP proteins are fundamental to their interaction (Supplementary Fig. 1a) 7 , it is unclear at the molecular level how different family members can interact in this class-specific yet promiscuous manner. Moreover, the predicted nature of the C-terminal Cas and NSP domains suggests an interaction mechanism that has not previously been observed. The NSP-binding portion of Cas proteins has been proposed to assume a focal adhesion targeting (FAT) domain-like fold, whereas the C-terminal domain of NSP proteins shares weak homology with Cdc25-homology domains (Cdc25-hd) found in GTPase exchange factors 15, 16 . However, the molecular mechanism of a direct Cdc25-hd-FAT interaction is currently without precedent, and the question of how this influences the putative activities of each domain while mechanically linking NSP and Cas signaling remains outstanding. a r t i c l e s To elucidate the molecular features enabling the formation of Cas-NSP signaling modules, we solved the crystal structures of the C-terminal region of unbound human BCAR3 and of the complex between human NSP3 and p130Cas. These structures, in combination with our biochemical and biological analyses, show that the Cdc25homology domain present in NSP proteins has evolved as an adaptor domain based on an enzymatic fold used in RasGEFs. This NSP structure tightly binds the FAT domain of Cas proteins using an extended interface. Furthermore, the class-specific interaction patterns we observed in the NSP3 and p130Cas interfaces are conserved among the members of both families. As a result, NSP and Cas proteins can promiscuously interact with each other to form various combinations of signaling modules that regulate cellular processes.
RESULTS

BCAR3 has an unconventional Cdc25-homology domain
To shed light on NSP protein signaling, we carried out structural and mechanistic investigations of the C-terminal domain of the bestcharacterized family member, BCAR3. After testing various constructs, we generated a soluble BCAR3 C-terminal domain (residues 502-825) with properties suitable for biochemical and structural investigation. Extensive screening of crystallization conditions led to well-diffracting BCAR3 crystals, which allowed us to solve the structure of BCAR3 at a resolution of 2.4 Å ( Fig. 1a and Table 1 ). The crystal structure contains four molecules of BCAR3 in the asymmetric unit, which overlay with high fidelity (r.m.s. deviation range 0.24-0.45 Å). The BCAR3 structure reveals a Ras-type GDP exchange factor architecture with unexpected modifications that clarify earlier contradictory findings about NSP proteins. BCAR3 adopts the overall fold of the Cdc25-homology domain structures solved so far with r.m.s. deviation values between the BCAR3 core and SOS, EPAC2 or RasGRF1 of 2.18 Å, 2.35 Å and 2.19 Å, respectively [17] [18] [19] (Supplementary Fig. 1b ). However, BCAR3 shows marked deviations in two distinct regions that lead to an unusual closed arrangement of the Cdc25-homology domain ( Fig. 1 and  Supplementary Fig. 2 ). In detail, helices α h and α i (nomenclature derived from SOS 17 ) each bend ~60° in orthogonal directions relative to their known GEF counterparts ( Fig. 1c,d) . Helix α h is also markedly shorter in BCAR3 than in other Cdc25-homology domains, and hydrophobic interactions by Leu713, Val714 and Leu716 cause the helix to be buried between α b and α i . Helix α i is broken into two portions (α i and α i* , Supplementary Fig. 2) , with α i folding toward the C terminus of α f in the Cdc25-homology domain core, achieving the closed BCAR3 conformation (Fig. 1) . The second, markedly different region comprises residues 565-592. This 'NSP-specific region' adopts a conformation that includes helices α NSPa and α NSPb and is well conserved in all NSP proteins.
Comparison of the BCAR3 structure with complexes of catalytically competent Cdc25-homology domains bound to their target GTPases showed that BCAR3 assumes a conformation incompatible with classical GEF function because its GTPase-binding site is completely occluded ( Fig. 1e and Supplementary Fig. 3a ). This occlusion is mainly achieved by the closed conformation of helix α i and its preceding linker comprising BCAR3 residues 718-736. In active 'open' Cdc25homology domains, helices α h and α i form a hairpin structure ( Fig. 1 ) that is crucial for activity because it displaces the switch 1 region of target GTPases 17, 20 . In fact, even slight conformational adjustments in this hairpin have substantial effects on exchange activity 19, 21 . Thus, the marked changes observed in BCAR3 suggest a considerable functional redirection of crucial GEF catalytic elements.
Closed BCAR3 lacks catalytic activity in vitro
To validate our structural observations and gain further insight into the functional properties of the BCAR3 C-terminal domain, we examined its ability to promote nucleotide exchange in vitro, which has been controversial in the literature 5, 16, [22] [23] [24] . Using BCAR3 502-825 , we assessed the ability of BCAR3 to induce GDP release from its putative target GTPase, Rap1A 25 . In contrast to positive controls with either EDTA or C3G (a bona fide GEF for Rap1A 26 ), which effectively promoted GDP release from Rap1A, we observed no activity for BCAR3 ( Fig. 1f ). Furthermore, we detected no interaction between the BCAR3 Cdc25-homology domain and Rap1A in in vitro pull-downs or isothermal titration calorimetry experiments (data not shown). We observed no catalytic activity for BCAR3, in accordance with the crystal structure, indicating that BCAR3 represents a noncatalytic adaption of the Cdc25-homology domain fold.
Structure of the NSP3-p130Cas complex
To further understand the function of the observed closed NSP conformation and clarify the molecular basis of NSP-Cas signaling modules, we next sought to obtain the structure of an NSP-Cas interaction complex. a r t i c l e s To this end, we extended our investigations to the BCAR3 relative NSP3 (SHEP1) and the prototypical Cas family member p130Cas. We identified constructs encoding residues 382-703 of NSP3 and residues 645-870 of p130Cas, which allowed us to generate the individual protein domains and complexes of NSP3 or BCAR3 bound to p130Cas ( Supplementary  Fig. 3b,c) . After extensive crystallization trials using both complexes, we solved the crystal structure of NSP3 bound to p130Cas at a resolution of 2.5 Å ( Fig. 2 and Table 1 ). The asymmetric unit of the crystal contains two NSP3-p130Cas complexes ( Supplementary  Fig. 4) , one of which is more clearly defined by electron density and is described below.
In agreement with our biochemical characterization ( Supplementary Figs. 3b,c and 5a-c) , the crystal structure shows that the two proteins form a 1:1 arrangement characterized by an extensive binding interface that buries 1,192 Å 2 . This substantial interface is in agreement with isothermal titration calorimetry results, which support a very tight (30 nM) interaction between p130Cas and the closely related NSP protein BCAR3 ( Supplementary Fig. 5d ). In the final model of the NSP3-p130Cas complex ( Fig. 2a) , NSP3 residues 386-698 are well defined by electron density with the exception of the loop between residues 599 and 612, which was not included in the model. The C-terminal domain of p130Cas is defined by electron density from residues 739-872 and adopts the four-helix bundle fold characteristic of FAT domains. The structure of NSP3 closely resembles a Cdc25-homology domain fold but, notably, shares the closed conformation observed for unbound BCAR3. A comparative backbone r.m.s. deviation of 0.97 Å between p130Cas-bound NSP3 and unbound BCAR3 underscores their close structural similarity ( Supplementary Fig. 6a ).
Closed NSP conformation is instrumental for Cas binding
The structure of the NSP3-p130Cas complex reveals that the closed conformation observed for the NSP3 C-terminal domain is key in enabling a Cdc25-hd-FAT domain interaction to form a previously undescribed signaling tether. This binding interface used by NSP3 and p130Cas can be divided into two main binding motifs ( Fig. 3 and Supplementary Fig. 7a ), which coincide with the two regions that deviate from the canonical Cdc25-homology domain fold of NSP3 (and BCAR3) and depend on the closed conformation of the domain. In the first motif, which we call site 1, a hydrophobic strip in helix α i of NSP3 interacts with a highly complementary surface on p130Cas. Site 2 is generated by a distinct region between α NSPa and α b of NSP3 and synergizes with site 1 to generate a tight signaling interaction.
Specifically, in site 1, Val616, Leu620 and Leu623 on helix α i pack into the hydrophobic groove between α 2 and α 3 of the p130Cas FAT domain ( Fig. 4a and Supplementary Fig. 7a ). These contacts are augmented by charged interactions mediated by Glu617, Glu624 and Arg627 of NSP3. In site 2, helix α NSPb and subsequent residues Glu465 and Leu469-Pro470-His471 interact with a predominantly hydrophobic groove between α 1 and α 2 of the p130Cas FAT domain. Supplementing the two main interfaces is a peripheral association of residues 386-388 from the N terminus of the NSP3 Cdc25-homology domain and Leu596 from helix α h of NSP3 ( Fig. 3c) , which contributes to a hydrophobic surface that links the site 1 and site 2 binding motifs.
As we discussed for BCAR3, the closed NSP3 conformation renders key elements of the Cdc25-homology domain incapable of participating a r t i c l e s in a canonical interaction with a Ras GTPase. Furthermore, the presence of Cas in the complex provides even greater steric hindrance to such a hypothetical GTPase interaction. To further validate this structural observation, we carried out in vitro nucleotide exchange assays with both unbound NSP3 and NSP3 in complex with the p130Cas FAT domain. In addition to Rap1A, we included Rap2A as a further putative target GTPase for NSP3 (ref. 27 ). We did not detect any in vitro exchange activity for either unbound or Cas-bound NSP3 ( Fig. 2c and Supplementary Fig. 6b ). This is in accordance with our structural observation that a closed conformation of the NSP3 Cdc25homology domain is essential for Cas binding.
Cas extends the paradigm of FAT domain interactions
In addition to revealing a critical adaption in NSP proteins, the NSP3-p130Cas complex provides the first atomic-resolution evidence that the C-terminal domains of Cas family proteins adopt a well-defined FAT domain-type four-helix bundle. Extensive hydrophobic interactions in the core of the domain suggest a stable arrangement of these helices (Fig. 3a) . Generally, FAT domains function as adaptor domains in focal adhesion signaling 28 , interacting with binding partners by recruiting helical motifs to surface grooves between their constituent helices [29] [30] [31] . However, these interactions are characteristically weak 29, 32 , whereas we observed a K d in the low nanomolar range for the binding of BCAR3 to the FAT domain of p130Cas, and tight binding between NSP3 and p130Cas ( Supplementary  Fig. 5 ). Although the tertiary structure of the C-terminal domain of p130Cas is nearly identical to that of other FAT domains (Fig. 3b) (Fig. 3c) using the bipartite binding motifs described above. First, the NSP3-p130Cas interaction at site 1 is accomplished through a binding groove between helices α 2 and α 3 of the p130Cas FAT domain. This interaction is reminiscent of the α 2 -α 3 binding site used by FAK and Pyk2 to bind paxillin 30, 31 , but p130Cas accommodates a distinctly longer helical stretch from NSP3 and buries a substantially greater surface area of 630 Å 2 (Fig. 3c) . The interaction at site 2, in contrast, has not been observed for other FAT-type fourhelical bundles. On p130Cas this interface is formed by helix α 1 and the C-terminal portion of helix α 2 of the FAT scaffold, and in concert with the extended site 1 interface, this achieves the tight binding of the p130Cas FAT domain to NSP proteins.
Biochemistry and biology of NSP-Cas complexes
To verify our structural findings, we carried out extensive biochemical and biological mutational studies. We designed structure-based mutations to disrupt binding elements while conserving the integrity of the protein domains (Fig. 4a) . All NSP3, BCAR3 and p130Cas mutant domains showed expression and solubility suitable for binding assays. The NSP3 R627E site 1 mutation or L469R site 2 mutation reduced complex formation with the p130Cas FAT domain in vitro, indicating that they substantially weaken the tight interaction ( Fig. 4b and Supplementary Fig. 7b ). In addition, the NSP3 L623E site 1 mutation completely abrogated the interaction even at the substantial concentrations used in our in vitro association experiments (Fig. 4b) .
In COS cells the full-length NSP3 L623E and L469R mutants also efficiently disrupted the complex with full-length p130Cas when the two proteins were coexpressed (Fig. 4c) . BCAR3 residues Leu744 and Arg748 correspond to Leu623 and Arg627 in NSP3, and when mutated also effectively disrupted the association with p130Cas in COS cells, confirming that different NSP proteins use a conserved p130Cas-binding mode (Fig. 4d) . Mutation of Arg743 in mouse BCAR3, corresponding to Arg748 in human BCAR3, has also been independently confirmed to disrupt p130Cas binding in recent studies 16, 33 . However, our in vitro results suggest that mutating Leu623 in NSP3 more effectively abrogates binding and therefore is a more potent probe for dissecting NSP3-Cas signaling modules. The potency of Leu623 is in agreement with its location in the hydrophobic core of the site 1 interaction, near the hydrophobic pair Phe794 and Leu787 of p130Cas (Fig. 4a) . In contrast, the salt bridge that Arg627 forms with Asp797 of p130Cas is more peripheral to the interface. We also examined interface mutations in p130Cas for their ability to counteract complex formation with NSP proteins. On the basis of our structural results, we chose Leu787, Phe794 and Asp797 as promising candidates for mutagenesis. Individual mutations of each of these residues (L787E, F794R and D797R) weakened the in vitro association of the p130Cas FAT domain with the NSP3 Cdc25-homology domain, whereas combinations of two mutations virtually abolished complex formation ( Fig. 4e and Supplementary  Fig. 7c ). In addition, the single p130Cas L787E and F794R mutations markedly reduced association between full-length p130Cas and NSP3 coexpressed in COS cells, confirming features of the NSP3-p130Cas complex in the cellular context (Fig. 4f) .
To examine the functional effects of targeted disruption of the NSP3-p130Cas module on cell migration, we tested the NSP3 L623E mutant in a Transwell migration assay. NSP3 promotes COS cell migration toward epidermal growth factor (EGF) as a chemoattractant in a Cas-dependent manner 27 . The specific interface mutant L623E abrogated the NSP3-dependent enhancement of COS cell migration toward EGF. Cells expressing this mutant showed migratory ability toward EGF similar to that of cells transfected with empty vector control (Fig. 4g,h) . This emphasizes the role of NSP-Cas module formation in linking cell motility and growth factor signaling and demonstrates the use of structural interface mutations for investigation of these signaling nodes.
Promiscuous yet class-specific NSP-Cas interactions
The structures of BCAR3, NSP3 and p130Cas provide not only insight into the C-terminal regions of NSP and Cas proteins and their interactions, but also a basis for applying features depicted in the wider context of NSP and Cas family signaling. To this end, we created molecular models for the C-terminal domains of the remaining family members on the basis of sequence profile alignments and the crystal structures solved in this work. We mapped primary interface residues onto these models and found that residues involved in formation of NSP-Cas complex are conserved within each family (Fig. 5a) . In agreement with this degree of conservation are residues that determine the core fold of NSP and Cas family C-terminal domains (Supplementary Fig. 8 ), whereas remaining surface features are considerably more divergent. This indicates that all three NSP family proteins have pervasively repurposed an enzymatic fold as a recruitment a r t i c l e s module, whereas Cas family proteins share a C-terminal FAT domain that accommodates the extended and tight binding interface observed in the NSP3-p130Cas complex. This extended interface, built upon the site 1 and site 2 binding motifs, is specific to NSP-Cas interactions yet allows different combinations of high-affinity mechanical linkages that integrate heterogeneous signaling pathways between the two families of proteins.
DISCUSSION
NSP and Cas family proteins interact with each other to form multidomain signaling modules. Members of both families have been linked to pathological processes such as breast cancer antiestrogen resistance 2, 34 and metastasis in melanoma and lung cancer 35, 36 . Analysis of an NSP3 knockout mouse line also suggests that these proteins may be involved in developmental disorders such as Kallmann syndrome 14 . Here we provide the first crystal structures of the unbound BCAR3 Cdc25-homology domain and the complex of the NSP3 Cdc25-homology domain with the FAT domain of the scaffolding protein p130Cas along with comprehensive biochemical and cell-based analyses of these regions. The Cdc25-homology domain is typically found in exchange factors for Ras-type small GTPases, which activate their target GTPases by catalyzing nucleotide exchange. Because the GTP-GDP-dependent cycling of Ras proteins is essential for many aspects of normal cellular physiology and has a critical role in diseases such as cancer, Cdc25-homology domains have been the focus of intense investigation. Several structural studies have revealed the molecular mechanisms underlying nucleotide exchange by Cdc25-homology domains 17, 19, 20 , including their regulation by additional interacting domains 18, 37 and other proteins including Ras itself 38 . In contrast to these catalytically active Cdc25-homology domains, the BCAR3 Cdc25-homology domain adopts an unexpected closed conformation with nearly all functional elements completely remodeled, rendering it incapable of carrying out canonical exchange factor function. Moreover, the structure of the NSP3-p130Cas complex shows that the same closed conformation is essential for a tight interaction with the FAT domain of p130Cas. Residues at the interface between NSP3 and p130Cas partially overlap with the interface suggested in a recent small-angle X-ray scattering (SAXS) study of the BCAR3-HEF1 complex 16 . However, this SAXS model assumes that the BCAR3 Cdc25-homology domain adopts a classical GEF-type fold similar to that of SOS, rather than the closed form we observed in the crystal structures of both isolated BCAR3 and NSP3 bound to p130Cas. The complete rearrangement of the helical hairpin in NSP proteins markedly modifies the Cdc25homology domain and creates a new binding surface. Consequently, NSP proteins use an aberrant enzymatic domain as an adaptor to link two multidomain signaling proteins.
Alignments of NSP proteins and Cas proteins show that both families (except the more distantly related CASS4) have preserved the residues that are critical for their interaction ( Fig. 5a and Supplementary  Fig. 8 ). This analysis explains how NSP and Cas proteins can tightly associate in a promiscuous but class-specific manner 11, 12, 39 . As a consequence, different pairwise combinations of NSP and Cas proteins can exploit functional differences such as divergent phosphorylation sites characteristic of the particular NSP-Cas protein module 3,6,10,27 (Fig. 5b) . In this manner, the signaling outcome can be fine-tuned by the particular NSP-Cas signaling nodes present in a cell type. This class-specific promiscuity is an effective structural mechanism for regulation of cellular signaling networks by NSP-Cas modules.
In summary, the previously unknown closed Cdc25-homology domain conformation of NSP proteins is an adaption enabling tight interaction with the C-terminal FAT domain of Cas proteins. This work reveals a structural paradigm used by the NSP class of adaptor complexes and provides a new basis for investigating the role of NSP-Cas signaling modules in cell migration, invasiveness and other key physiological and pathological processes. 
METHODS
Methods
ONLINE METHODS
Protein purification and crystallization. Expression constructs for crystallization were cloned into pET29b using standard PCR-based methods, and mutants were generated using QuikChange site-directed mutagenesis. BCAR3 502-825 (Uniprot: O75815) was expressed with a C-terminal His 6 tag in E. coli BL21(DE3) and was purified by Ni 2+ affinity chromatography followed by anion exchange (Source Q 10/10), leading to typical final protein concentrations of 10-12 mg ml −1 BCAR3 in 10 mM HEPES, pH 7.9, 100 mM NaCl and 2 mM DTT. Initial crystals of wild-type protein grew by vapor diffusion from 15-20% (w/v) PEG3350, 0.04 M citric acid and 0.06 M Bis-Tris propane, pH 6.4, at room temperature. A contaminant lower-molecular-mass species was avoided by creating a BCAR3 502-825 M536L construct, and crystals for data collection were grown after mixing 3 µl of BCAR3 with 1.5 µl of the original mother liquor incorporating 4% (w/v) polypropylene glycol 400 additive.
The complex between NSP3 (Uniprot: Q8N5H7 isoform 2) and p130Cas (Uniprot: P56945) was prepared by mixing cell lysates after expression of C-terminally His-tagged NSP3 382-703 and untagged p130Cas 645-870 . The complex was purified by both affinity and anion-exchange chromatography in a final buffer consisting of 10 mM Tris, pH 8.0, ~150 mM NaCl and 2 mM DTT. Initial crystals were obtained using wild-type NSP3-p130Cas proteins, whereas a construct incorporating C497S and C598S mutations in NSP3 (referred to as NSP3) crystallized in an identical manner and was used for data collection. Final crystals were prepared by mixing complex with mother liquor containing PEG3350 and sodium citrate, pH 7.8, in a 2:1 ratio. Diffraction was markedly improved by exchange of sodium citrate for sodium acetate in mother liquor after crystal growth. Both BCAR3 and NSP3-p130Cas crystals were prepared for data collection by introducing glycerol up to 20% and 15% (w/v), respectively, before flash freezing.
Structure determination and refinement. Diffraction data from BCAR3 crystals was collected using a Rigaku Superbright rotating-anode source. Data was integrated and scaled with XDS 40 and SCALA 41 and the structure of BCAR3 was solved by molecular replacement in Phaser 42 using the structure of NSP3 solved below as search model. The model was refined using Phenix 43 and rebuilt using COOT 44 . Phases of the NSP3-p130Cas complex were obtained from crystals containing SeMet-derivatized NSP3 and by soaking native complex crystals in 10 mM thimerosal for 1 h before flash freezing. Derivative data were collected at wavelengths corresponding to the peak of anomalous dispersion for selenium and mercury at National Synchrotron Light Source beamline X29. Data were integrated, reduced and scaled with HKL2000 (ref. 45) , or XDS and SCALA. Phasing by MIRAS and density modification were carried out using AutoSharp 46 and partially built using Buccaneer 41 . The model was completed in COOT and refined against native diffraction data using Phenix. Data collection and final refinement statistics of both structures are in Table 1 . Molecular models were created using FFAS 47 and Modeller 48 , and all figures were created using PyMOL (http://pymol.org/). (Uniprot P62834) 49 , rRas (Uniprot P10301), Rap2 1-167 (Uniprot P10114) 50 and C3G 830-1077 (Uniprot Q13905) 26 were created by ligationindependent cloning into a modified pET vector incorporating an N-terminal His tag. Proteins were purified by affinity chromatography and size-exclusion chromatography on a Superdex 200 column.
Protein biochemistry. Expression constructs for target GTPases Rap1a
Isothermal titration calorimetry was carried out using a MicroCal iTC 200 calorimeter, and proteins at stated concentrations were prepared in a matched buffer containing 10 mM Tris, 100 mM NaCl and 0.5 mM Tris-(2carboxyethyl)phosphine (TCEP). Analytical ultracentrifugation sedimentation equilibrium experiments were done in ProteomeLab XL-I (BeckmanCoulter) analytical ultracentrifuge with protein in 20 mM Tris, pH 8.0, 150 mM NaCl and 1 mM DTT. Analysis was done using HeteroAnalysis software (by J.L. Cole and J.W. Lary, University of Connecticut; http://www.biotech.uconn.edu/auf/). Nucleotide exchange assays. For GDP exchange assays, GTPases were loaded with mant-GDP using standard protocols 51 , and exchange of mantGDP in an excess of unlabeled GDP was measured by tracking fluorescence at 460 nm after excitation at 355 nm in a Molecular Devices fMax fluorescent plate reader at 25 °C. Exchange assays were carried out with ~0.3 µM GTPase in a buffer containing 10 mM HEPES, pH 7.8, 100 mM NaCl, 0.5 mM TCEP and 2 mM MgCl 2 , and ~0.1 mg ml −1 BSA was included to stabilize GTPases in solution.
Antibodies.
A rabbit polyclonal antibody to the 11 C-terminal residues of NSP3 was used for immunoprecipitations (10 µg) and a Shep1 SH2 antibody 23 was used for immunoblotting (0.5 µg ml −1 ). The following primary antibodies were also used: p130Cas (BD Transduction laboratories; 1:600 dilution of a 0.25 mg ml −1 stock for immunoblotting), BCAR3 (Santa Cruz, 1 µg ml −1 for immunoblotting and 2 µg for immunoprecipitation) and GFP (GeneTex; 1 µl serum for immunoprecipitation).
Transwell migration assays. Cells co-transfected with NSP3 constructs in pcDNA3 and the peGFP-N3 plasmid (Clontech) were seeded on Transwell filters coated on both sides with 10 mg ml −1 fibronectin (Millipore). EGF (20 ng ml −1 ) was added in the lower chamber as a chemoattractant, in comparison to no EGF as a control. The cells were allowed to migrate for 4 h, and the mean eGFP intensity from transfected cells on the bottom side of the filters was measured from microscope images. Comparisons between wells with EGF were made by one-way ANOVA and Dunnett's post-hoc test. Similar results were obtained in four different experiments.
Probing NSP-Cas interactions in cells. COS cells were cultured in DMEM supplemented with 10% (w/v) FBS and were transiently transfected with the indicated plasmids using Lipofectamine 2000 (Invitrogen). At 24 h after transfection, cells were lysed in RIPA buffer and centrifuged at 16,000g for 15 min at 4 °C. For immunoprecipitations, cell lysates were incubated at 4 °C with antibody for 2 h, followed by incubation with Gamma-bind beads (GE Health Care Health Sciences) for 1 h. Beads were washed with RIPA buffer and immunocomplexes were eluted by boiling for 5 min in SDS sample buffer. Extracts were separated by SDS-PAGE and transferred to a PVDF membrane (Millipore). After primary antibody incubation, membranes were probed with HRP-conjugated anti-mouse or anti-rabbit antibodies (Millipore; 1:5,000 dilution).
